BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 36657432)

  • 1. The Aryl Hydrocarbon Receptor Ligand 6-Formylindolo(3,2-b)carbazole Promotes Estrogen Receptor Alpha and c-Fos Protein Degradation and Inhibits MCF-7 Cell Proliferation and Migration.
    Cano-Sánchez J; Murillo-González FE; de Jesús-Aguilar J; Cabañas-Cortés MA; Tirado-Garibay AC; Elizondo G
    Pharmacology; 2023; 108(2):157-165. PubMed ID: 36657432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The aryl hydrocarbon receptor mediates degradation of estrogen receptor alpha through activation of proteasomes.
    Wormke M; Stoner M; Saville B; Walker K; Abdelrahim M; Burghardt R; Safe S
    Mol Cell Biol; 2003 Mar; 23(6):1843-55. PubMed ID: 12612060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor subtype- and promoter-specific modulation of aryl hydrocarbon receptor-dependent transcription.
    Wihlén B; Ahmed S; Inzunza J; Matthews J
    Mol Cancer Res; 2009 Jun; 7(6):977-86. PubMed ID: 19470599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel prenylflavone restricts breast cancer cell growth through AhR-mediated destabilization of ERα protein.
    Tiong CT; Chen C; Zhang SJ; Li J; Soshilov A; Denison MS; Lee LS; Tam VH; Wong SP; Xu HE; Yong EL
    Carcinogenesis; 2012 May; 33(5):1089-97. PubMed ID: 22345291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor α and aryl hydrocarbon receptor independent growth inhibitory effects of aminoflavone in breast cancer cells.
    Brinkman AM; Wu J; Ersland K; Xu W
    BMC Cancer; 2014 May; 14():344. PubMed ID: 24885022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive expression of AhR and BRCA-1 promoter CpG hypermethylation as biomarkers of ERα-negative breast tumorigenesis.
    Romagnolo DF; Papoutsis AJ; Laukaitis C; Selmin OI
    BMC Cancer; 2015 Dec; 15():1026. PubMed ID: 26715507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc finger nuclease-mediated knockout of AHR or ARNT in human breast cancer cells abolishes basal and ligand-dependent regulation of CYP1B1 and differentially affects estrogen receptor α transactivation.
    Ahmed S; Wang A; Celius T; Matthews J
    Toxicol Sci; 2014 Mar; 138(1):89-103. PubMed ID: 24299737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol and 3,3'-Diindolylmethane Differentially Regulate Aryl Hydrocarbon Receptor and Estrogen Receptor Alpha Activity through Multiple Transcriptomic Targets in MCF-7 Human Breast Cancer Cells.
    Das S; Somisetty VS; Ulven SM; Matthews J
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the aryl hydrocarbon receptor is not required for the proliferation, migration, invasion, or estrogen-dependent tumorigenesis of MCF-7 breast cancer cells.
    Spink BC; Bennett JA; Lostritto N; Cole JR; Spink DC
    Mol Carcinog; 2013 Jul; 52(7):544-54. PubMed ID: 22388733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aryl hydrocarbon receptor modulation of estrogen receptor α-mediated gene regulation by a multimeric chromatin complex involving the two receptors and the coregulator RIP140.
    Madak-Erdogan Z; Katzenellenbogen BS
    Toxicol Sci; 2012 Feb; 125(2):401-11. PubMed ID: 22071320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanism of inhibitory aryl hydrocarbon receptor-estrogen receptor/Sp1 cross talk in breast cancer cells.
    Khan S; Barhoumi R; Burghardt R; Liu S; Kim K; Safe S
    Mol Endocrinol; 2006 Sep; 20(9):2199-214. PubMed ID: 16675542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor-α and aryl hydrocarbon receptor involvement in the actions of botanical estrogens in target cells.
    Gong P; Madak-Erdogan Z; Flaws JA; Shapiro DJ; Katzenellenbogen JA; Katzenellenbogen BS
    Mol Cell Endocrinol; 2016 Dec; 437():190-200. PubMed ID: 27543265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The aryl hydrocarbon receptor and estrogen receptor alpha differentially modulate nuclear factor erythroid-2-related factor 2 transactivation in MCF-7 breast cancer cells.
    Lo R; Matthews J
    Toxicol Appl Pharmacol; 2013 Jul; 270(2):139-48. PubMed ID: 23583297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-Formylindolo[3,2-b]carbazole (FICZ) Enhances The Expression of Tumor Suppressor miRNAs, miR-22, miR-515-5p, and miR-124-3p in MCF-7 Cells.
    Mobini K; Banakar E; Tamaddon G; Mohammadi-Bardbori A
    Cell J; 2020 Apr; 22(1):115-120. PubMed ID: 31606975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbidopa suppresses estrogen receptor-positive breast cancer via AhR-mediated proteasomal degradation of ERα.
    Chen Z; Xia X; Chen H; Huang H; An X; Sun M; Yao Q; Kim K; Zhang H; Chu M; Chen R; Bhutia YD; Ganapathy V; Kou L
    Invest New Drugs; 2022 Dec; 40(6):1216-1230. PubMed ID: 36070108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dioxin and estrogen signaling in lung adenocarcinoma cells with different aryl hydrocarbon receptor/estrogen receptor α phenotypes.
    Kuo LC; Cheng LC; Lin CJ; Li LA
    Am J Respir Cell Mol Biol; 2013 Dec; 49(6):1064-73. PubMed ID: 23855798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tryptophan derivative 6-formylindolo[3,2-b]carbazole, FICZ, a dynamic mediator of endogenous aryl hydrocarbon receptor signaling, balances cell growth and differentiation.
    Rannug A; Rannug U
    Crit Rev Toxicol; 2018 Aug; 48(7):555-574. PubMed ID: 30226107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hexachlorobenzene induces cell proliferation and IGF-I signaling pathway in an estrogen receptor alpha-dependent manner in MCF-7 breast cancer cell line.
    García MA; Peña D; Alvarez L; Cocca C; Pontillo C; Bergoc R; de Pisarev DK; Randi A
    Toxicol Lett; 2010 Feb; 192(2):195-205. PubMed ID: 19879930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of CC-chemokine ligand 5 by aryl hydrocarbon receptor ligands.
    Morino-Koga S; Uchi H; Tsuji G; Takahara M; Kajiwara J; Hirata T; Furue M
    J Dermatol Sci; 2013 Oct; 72(1):9-15. PubMed ID: 23810773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer.
    Gonzalez TL; Hancock M; Sun S; Gersch CL; Larios JM; David W; Hu J; Hayes DF; Wang S; Rae JM
    Breast Cancer Res Treat; 2020 Apr; 180(3):611-622. PubMed ID: 32067153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.